[Estimation of medroxyprogesterone acetate (MPA) and etoposide against a human uterine endometrial cancer].
Ishizaki
T
T
Dept. of Obstetrics and Gynecology, Gamoucyo Hospital.
Yamamoto
T
T
Itoh
R
R
Yasuda
J
J
Fujita
H
H
Okada
H
H
D000818:Animals; D002455:Cell Division / Q000187:drug effects; D004357:Drug Synergism; D016889:Endometrial Neoplasms / Q000473:pathology*; D005047:Etoposide / Q000008:administration & dosage / Q000494:pharmacology*; D005260:Female; D006801:Humans; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage / Q000494:pharmacology*; D051379:Mice; D008819:Mice, Nude; D013370:Subrenal Capsule Assay; D013778:Tetrazolium Salts; D013844:Thiazoles
D013778:Tetrazolium Salts; D013844:Thiazoles; D005047:Etoposide; D017258:Medroxyprogesterone Acetate